Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.5 $2,927 - $4,390
2,927 Added 26.27%
14,071 $18,000
Q2 2023

Aug 14, 2023

SELL
$1.04 - $1.64 $81 - $127
-78 Reduced 0.7%
11,144 $12,000
Q1 2023

May 15, 2023

SELL
$1.39 - $3.24 $25,459 - $59,343
-18,316 Reduced 62.01%
11,222 $17,000
Q4 2022

Feb 14, 2023

SELL
$2.32 - $3.68 $75,003 - $118,970
-32,329 Reduced 52.26%
29,538 $74,000
Q3 2022

Nov 14, 2022

SELL
$2.87 - $7.01 $294,375 - $719,015
-102,570 Reduced 62.38%
61,867 $199,000
Q2 2022

Aug 15, 2022

SELL
$3.76 - $6.29 $785,911 - $1.31 Million
-209,019 Reduced 55.97%
164,437 $922,000
Q1 2022

May 16, 2022

SELL
$5.03 - $9.61 $924,503 - $1.77 Million
-183,798 Reduced 32.98%
373,456 $2.31 Million
Q4 2021

Feb 14, 2022

SELL
$8.12 - $10.37 $1.6 Million - $2.05 Million
-197,239 Reduced 26.14%
557,254 $4.98 Million
Q3 2021

Nov 15, 2021

BUY
$7.48 - $11.38 $2.3 Million - $3.49 Million
307,058 Added 68.63%
754,493 $7.34 Million
Q2 2021

Aug 16, 2021

BUY
$7.16 - $9.56 $3.2 Million - $4.28 Million
447,435 New
447,435 $3.69 Million
Q1 2021

May 17, 2021

SELL
$8.52 - $19.21 $545,135 - $1.23 Million
-63,983 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$9.3 - $15.19 $98,198 - $160,391
10,559 Added 19.76%
63,983 $595,000
Q3 2020

Nov 16, 2020

BUY
$8.24 - $30.8 $179,590 - $671,286
21,795 Added 68.91%
53,424 $726,000
Q2 2020

Aug 14, 2020

SELL
$7.46 - $23.42 $538,470 - $1.69 Million
-72,181 Reduced 69.53%
31,629 $612,000
Q1 2020

May 14, 2020

BUY
$0.91 - $17.81 $94,467 - $1.85 Million
103,810 New
103,810 $791,000
Q1 2018

May 15, 2018

SELL
$1.56 - $3.2 $22,560 - $46,278
-14,462 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$2.38 - $6.72 $147,091 - $415,316
-61,803 Reduced 81.04%
14,462 $38,000
Q3 2017

Nov 14, 2017

BUY
$3.85 - $6.3 $293,620 - $480,469
76,265
76,265 $477,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $35.8M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.